This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marro, M. L. Articles by Muro, A. F. Search for Related Content PubMed PubMed Citation Articles by Marro, M. L. Articles by Muro, A. F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Remodeling Apoptosis Gene expression Gene regulation Hypertension - basic studies Myogenesis

(Hypertension. 2000;36:449.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Hypertension in ß-Adducin–Deficient Mice

Martín L. Marro¹; Oscar U. Scremin¹; Maria C. Jordan; Ly Huynh; Fabiola Porro; Kenneth P. Roos; Sreko Gajovi; Francisco E. Baralle; Andrés F. Muro

From the International Center for Genetic Engineering and Biotechnology, Trieste, Italy (M.L.M., F.P., S.G., F.E.B., A.F.M.); Department of Physiology, School of Medicine, University of California at Los Angeles (O.U.S., M.C.J., L.H., K.P.R.); Veterans Affairs GLA Healthcare System, Los Angeles, California (O.U.S., L.H.); and Department of Histology and Embryology, School of Medicine, University of Zagreb, Croatia (S.G.).

Correspondence to A.F. Muro, ICGEB, Padriciano, 99, 34012 Trieste, Italy. E-mail muro{at}icgeb.trieste.it

Abstract—Polymorphic variants of the cytoskeletal protein adducin have been associated with hypertension in humans and rats. However, the direct role of this protein in modulating arterial blood pressure has never been demonstrated. To assess the effect of ß-adducin on blood pressure, a ß-adducin–deficient mouse strain (-/-) was studied and compared with wild-type controls (+/+). Aortic blood pressure was measured in nonanesthetized, freely moving animals with the use of telemetry implants. It is important to note that these mice have at least 98% of C57Bl/6 genetic background, with the only difference from wild-type animals being the ß-adducin mutation. We found statistically significant higher levels of systolic blood pressure (mm Hg) (mean±SE values: -/-: 126.94±1.14, n=5; +/+: 108.06±2.34, n=6; P0.0001), diastolic blood pressure (-/-: 83.54±1.07; +/+: 74.87±2.23; P0.005), and pulse blood pressure (-/-: 43.32±1.10; +/+: 33.19±1.96; P0.001) in ß-adducin–deficient mice. Western blot analysis showed that as a result of the introduced genetic modification, ß-adducin was not present in heart protein extracts from -/- mice. Consequently, this deficiency produced a sharp decrease of -adducin and a lesser reduction in -adducin levels. However, we found neither cardiac remodeling nor modification of the heart function in these animals. This is the first report showing direct evidence that hypertension is triggered by a mutation in the adducin gene family.

Key Words: hypertension, genetic • adducin • mice, knockout • echocardiography • cytoskeleton • telemetry • electrocardiography

This article has been cited by other articles:

				N. Kato, T. Miyata, Y. Tabara, T. Katsuya, K. Yanai, H. Hanada, K. Kamide, J. Nakura, K. Kohara, F. Takeuchi, et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project Hum. Mol. Genet., February 14, 2008; 17(4): 617 - 627. [Abstract] [Full Text] [PDF]

				L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]

				Correction J. Neurosci., April 6, 2005; 25(14): . [Full Text] [PDF]

				P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]

				H. Yang, P. Y. Reaves, M. J. Katovich, and M. K. Raizada Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension Hypertension, February 1, 2004; 43(2): 324 - 328. [Abstract] [Full Text] [PDF]

				H. Yang, S. C. Francis, K. Sellers, M. DeBarros, C. Sun, C. Sumners, C. M. Ferrario, M. J. Katovich, A. F. Muro, and M. K. Raizada Hypertension-Linked Decrease in the Expression of Brain {gamma}-Adducin Circ. Res., October 4, 2002; 91(7): 633 - 639. [Abstract] [Full Text] [PDF]

				B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF]

				D. P. Holschneider, O. U. Scremin, D. R. Chialvo, K. Chen, and J. C. Shih Heart rate dynamics in monoamine oxidase-A- and -B-deficient mice Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1751 - H1759. [Abstract] [Full Text] [PDF]